جست‌وجوی استاد و پژوهشگر

Jianjun Chenمشاهده پروفایل

استاد

• RNA Epigenetics
• DNA Epigenetics
• Cancer Biology
• +۷ مورد دیگر

Jianjun Chen, Ph.D. serves as Professor and Chair of the Department of Systems Biology and Director of the Center for RNA Biology and Therapeutics at City of Hope's Beckman Research Institute. Appointed Chair in August 2020, he previously served as Professor and Vice Chair from 2017-2020. He also holds the Simms/Mann Family Foundation Chair in Systems Biology since 2018. Dr. Chen's research focuses on RNA and DNA epigenetic mechanisms in cancer development and therapy resistance. His laboratory has made seminal contributions to understanding RNA modifications including N⁶-methyladenosine (m⁶A), 5-methylcytosine (m⁵C), and 7-methylguanosine (m⁷G), and their roles in cancer initiation, progression, drug resistance, and immune evasion. The lab also studies DNA epigenetic regulation through TET proteins and develops novel therapeutic strategies targeting epigenetic regulators. His recent publications reveal trends in RNA epigenetics, cancer metabolism, immune evasion mechanisms, and therapeutic targeting of epigenetic regulators. His work spans multiple cancer types including leukemia, lymphoma, and solid tumors, with emphasis on translating basic discoveries into clinical applications. Research Scholar of the American Cancer Society (2011) Scholar of The Leukemia & Lymphoma Society (2017) Researcher of the Year, The Pamela B. Katten Memorial Leukemia Research Foundation Award (2014) The Leukemia & Lymphoma Society Scholar CDP Achievement Award (2022) Fellow of the American Association for the Advancement of Science (AAAS) (2023) Dr. Chen's research program is supported by multiple R01 grants from the National Cancer Institute. His laboratory actively mentors researchers and has developed several small-molecule inhibitors with strong therapeutic potential in preclinical models. The Chen Laboratory is dedicated to translating fundamental discoveries in RNA and DNA epigenetics into effective clinical therapies for cancer patients. The laboratory operates within City of Hope's comprehensive cancer center, collaborating with clinical teams to bridge basic research and patient care. Current projects focus on developing prognostic systems for cancer risk stratification and creating targeted therapeutic strategies that inhibit aberrant epigenetic regulators such as FTO, IGF2BP2, YTHDF2, METTL16, and TET1.

Eduardo Eyrasمشاهده پروفایل

استاد

• RNA Biology
• Cancer Research
• Long-read Sequencing Technologies
• +۴ مورد دیگر

Eduardo Eyras is a Professor at the Australian National University (ANU) and EMBL Australia Group Leader, leading research in computational RNA biology and cancer genomics. He directs the Centre for Computational Biomedical Sciences and is part of the Shine-Dalgarno Centre for RNA Innovation. His work focuses on transcriptome and epitranscriptome analysis using long-read sequencing, machine learning, and computational methods to study cancer mechanisms. Eyras holds a PhD in Mathematics from the University of Groningen (1999) and previously led research at the Sanger Institute and Pompeu Fabra University. Affiliations: Director, Centre for Computational Biomedical Sciences Researcher, Shine-Dalgarno Centre for RNA Innovation Member, Division of Genome Sciences and Cancer Leader, The Eyras Group - Computational RNA Biology Research Interests: Development of algorithms for long-read sequencing Machine learning applications in RNA biology Epitranscriptomic modifications and cancer Therapeutic mRNA platform steering Key Projects: Novel algorithms for transcriptome variation analysis Predictive models of RNA modifications in disease Ribosomal DNA variation analysis Advisees & Grants: Supervises PhD students (e.g., Favour Oyelami, Stefan Prodic) and leads ARC-funded projects on mRNA diagnostics and epitranscriptomic therapies. Collaborates with global teams on forensic genomics, cancer drug resistance, and AI-driven translational research. Labs/Teams: Leads the Eyras Group, collaborating with the Hannan Group (Cancer Therapeutics) and Shirokikh Group (Protein Biosynthesis).

Ian J. Mohrمشاهده پروفایل

استاد

• Post-transcriptional gene regulation
• Virology
• RNA Biology
• +۳ مورد دیگر

Ian J. Mohr, PhD is a Professor in the Department of Microbiology at NYU Grossman School of Medicine. His research focuses on post-transcriptional control of gene expression during virus infection, intersecting virology, RNA biology, and genome integrity. Education PhD in Molecular Biology from Stony Brook University Postdoctoral Training at University of California, Berkeley (Molecular and Cell Biology) Research Interests Mohr's lab investigates how physiological stress and viral infections dysregulate translational control, RNA metabolism, and gene expression. Key areas include: RNA modifications (e.g., m6A) in viral replication Translational control during viral infection Host antiviral responses targeting mRNA decay Stress signaling in virus-infected cells Herpesvirus latency and reactivation Recent Trends in Research Mohr's recent publications emphasize RNA modifications and translational regulation in herpesvirus infections, particularly HCMV and HSV-1. His work explores: Epitranscriptomic mechanisms in viral RNA accumulation Integration of stress response pathways with viral replication Computational approaches for RNA modification detection Role of nuclear body assembly in viral pathogenesis Laboratory Mohr leads the Mohr Lab at NYU Langone's virology research group. His lab collaborates extensively with other virology and RNA biology teams, particularly with Associate Professor Angus C. Wilson's lab, with which he has co-mentored trainees and secured joint grants.

Timothy Bredyمشاهده پروفایل

دانشیار

• Epigenetics
• Fear-Related Memory
• RNA Biology
• +۶ مورد دیگر

Associate Professor Timothy Bredy is a leading figure in cognitive neuroepigenetics at the Queensland Brain Institute (QBI) , focusing on how epigenetic modifications and RNA dynamics regulate fear-related memory and psychiatric disorders like PTSD. His research explores the interplay between environmental experiences and genomic activity, particularly through non-coding RNA and DNA methylation. University: University of Queensland School: Faculty of Health, Medicine and Behavioural Sciences Role: Professorial Research Fellow and Group Leader Research Interests span epigenetic mechanisms in memory formation, RNA modifications in synaptic plasticity, and therapeutic applications for anxiety disorders. He pioneered discoveries linking dynamic DNA structures (e.g., G-quadruplexes) and RNA methylation to memory stability. Recent Work includes studies on RNA-based therapeutics, stress-induced epigenetic inheritance, and synaptic long noncoding RNA activity. His scientific awards encompass NHMRC and ARC grants for neuroepigenetics research. Key Collaborators: Paul Marshall, Esmi Zajaczkowski Labs: Bredy Laboratory at QBI

• RNA Splicing
• Aging Biology
• Genetics
• +۳ مورد دیگر

Aykut Shen holds a PhD and is a Researcher affiliated with the RNA (epi)Genetics Lab at the University of East Anglia (UEA), specifically within the School of Biological Sciences. His work focuses on molecular mechanisms underlying RNA processing and aging, with a strong emphasis on epigenetic regulation and developmental biology. Recent research includes studies on insulin signaling's role in reproductive aging and the critical function of U6 snRNA m6A modifications in RNA splicing accuracy. His publications span Aging Cell and Nucleic Acids Research, demonstrating contributions to both basic biology and translational insights into aging. No scientific awards or grants are explicitly listed, but his research has garnered citations and social media engagement across platforms like Bluesky and Mendeley. Shen collaborates internationally, with projects involving institutions in multiple countries, as indicated by his network map. His lab's work bridges model organisms (C. elegans) and human systems, highlighting translational potential in genetic and epigenetic research.

• Biochemistry
• RNA Structure
• Structural Biology
• +۶ مورد دیگر

Jessica Brown is an Associate Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, where she leads a research group focused on RNA structure and function. Her lab investigates the structural, biochemical, and cellular roles of RNA triple helices, with a particular emphasis on the MALAT1 triple helix and its implications in cancer biology. Education: Ph.D. in Biochemistry, The Ohio State University (2010) B.S. in Chemistry and Biological Sciences, Wright State University (2005) Her research lies at the intersection of biochemistry, structural biology, and molecular oncology. She explores fundamental questions about RNA triple helix formation, stability, protein interactions, and degradation pathways. Using techniques such as X-ray crystallography, cryo-EM, and high-throughput assays, her work aims to uncover the biophysical principles governing RNA triplexes and their regulatory roles in human disease. The recent publications from her lab highlight a strong trend in RNA modification, non-coding RNA structure, and therapeutic targeting of oncogenic RNAs. Her studies span from mechanistic enzymology (e.g., METTL16 kinetics) to disease-associated structural rearrangements in MALAT1, reflecting a multidisciplinary approach that bridges basic science and translational applications. Scientific Awards: NIH Pathway to Independence Award (K99/R00), 2014–2019 American Cancer Society Postdoctoral Fellowship, 2012–2014 OSU Presidential Fellowship, 2010 American Heart Association Predoctoral Fellowship, 2008–2010 Dr. Brown advises graduate students and postdoctoral researchers in her lab, fostering training in cutting-edge biochemical and structural methods. While specific grant details are not listed, her sustained research output and prestigious fellowships indicate active external funding. Her lab is positioned at the forefront of RNA structural biology, with future work likely to expand the understanding of the 'triplexome' and develop tools for targeting stable RNA structures in disease. Labs and Research Teams: The Brown Laboratory at the University of Notre Dame employs a collaborative, interdisciplinary team of researchers using structural, biochemical, and cellular approaches to study RNA triple helices. The lab actively recruits graduate and postdoctoral trainees and contributes to major discussions in RNA biology and epitranscriptomics.

Geoffrey Bartonمشاهده پروفایل

استاد

• Bioinformatics
• Computational Biology
• Protein Structure Prediction
• +۴ مورد دیگر

Professor Geoffrey Barton is the Chair of Bioinformatics at the Computational Biology department within the School of Life Sciences at the University of Dundee . With a career spanning decades, he has been pivotal in advancing bioinformatics tools and methodologies for analyzing biological data, particularly in protein structure prediction and RNA sequencing. Core Research Interests : Protein structure and function prediction, computational methods for large biological datasets, small RNA analysis, and integration with wet-lab collaborations across plants, model organisms, and human disease. Awards : Fellow of the Royal Society of Edinburgh (2019) Fellow of the Royal Society of Biology (2011) Brian Cox Prize for Excellence in Public Engagement with Research (2023) Publications and Software : He leads the development of widely used tools like JPred (25,000+ predictions/month) and Jalview (55,000+ installations). His group's work spans proteomics, transcriptomics, and structural genomics, addressing questions in basic science and clinical applications. Media and Collaboration : Available for media commentary on bioinformatics and computational biology, he collaborates extensively with international institutions, including the University of Cambridge and Oxford.

Laura Leightonمشاهده پروفایل

پژوهشگر ارشد

• RNA Biology
• mRNA Therapeutics
• Gene Therapy
• +۳ مورد دیگر

Dr. Laura Leighton is a Postdoctoral Research Fellow in the mRNA Sciences group at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. Her research focuses on RNA biology, particularly the functional characterization of RNA molecules and their roles in cancer therapy and neurological processes. She leads the development of mRNA-based therapeutics for liver cancer, leveraging lipid nanoparticle (LNP) delivery systems to target intracellular cancer proteins. Dr. Leighton holds a PhD from the Queensland Brain Institute (2021), where her work, supported by the Westpac Future Leaders Scholarship, explored small noncoding RNAs in fear-related learning and memory. She completed her postdoctoral training under Dr. Seth Cheetham at AIBN in 2023. Her educational background includes a Bachelor of Science and Bachelor of Science (Honours) from The University of Queensland. Her research interests integrate molecular biology, neuroscience, and translational medicine, with a focus on RNA modifications (e.g., m6A), long noncoding RNAs, and the epigenetic regulation of memory processes. Key themes in her work include fear extinction mechanisms, synaptic plasticity, and the application of mRNA therapeutics in cancer treatment. Dr. Leighton’s articles consistently explore RNA-driven mechanisms in memory and disease. Recent work highlights the role of DNA G-quadruplex structures in memory regulation, the interplay between stress hormones and sperm RNA dysregulation, and the synthesis of novel long noncoding RNAs (e.g., ADRAM) that drive fear extinction. Her findings bridge basic neuroscience and clinical applications, emphasizing RNA’s dynamic role in health and disease. Awards: Westpac Future Leaders Scholarship (2017) Grants: TdC Mid Career Grant (Targeting liver cancer with mRNA therapies), Prader Willi Syndrome Research Grant (2022–2024) She is actively involved in supervising research students and contributes to the development of advanced drug delivery systems targeting liver cancers. Her lab is part of AIBN’s mRNA Sciences team, collaborating on projects that translate RNA-based discoveries into clinical solutions.

Dario Leisterمشاهده پروفایل

استاد

• Regulation of Photosynthesis
• Retrograde Signaltransduction
• Bio-Hybridsystems for Photovoltaik and Photokatalyse
• +۳ مورد دیگر

Prof. Dr. Dario Leister is a Chair of Plant Molecular Biology/Botany at the Ludwig-Maximilians-University Munich (LMU) , where he leads research on photosynthesis regulation, retrograde signaling, and bio-hybrid systems for photovoltaics. His lab focuses on chloroplast functions, stress responses, and synthetic biology to enhance photosynthetic efficiency. Education: Diploma in Biochemistry (University of Tübingen, 1993); PhD in Genetics (Max-Planck-Institute, 1995); Habilitation in Genetics (University of Tübingen, 2003). Recent research trends include optimizing photosynthesis under fluctuating light, engineering cyanobacterial systems for stress tolerance, and exploring chloroplast-mitochondria interactions. His work spans molecular genetics, RNA biology, and nanotechnology-based applications. Scientific Awards: Top Author Award (ASPB, 2015); Karl-Lohmann-Prize (2003); Heisenberg Scholarship (DFG, 2003-2005); EMBO Long-Term Fellowship (1997-1998). He chairs the Transregio 175 consortium ( The Green Hub ) and serves on the Faculty Board of LMU's Faculty of Biology. His lab investigates chloroplast development, redox signaling, and adaptive evolution in plants.

Nancy M. Boniniمشاهده پروفایل

استاد

• Neurodegeneration
• Neurogenetics
• Molecular genetics of neurodegenerative disease
• +۱۳ مورد دیگر

Nancy M. Bonini, Ph.D., is the Florence R.C. Murray Professor of Biology in the School of Arts and Sciences at the University of Pennsylvania , an Investigator of the Howard Hughes Medical Institute , and holds secondary appointments in Cell & Developmental Biology and Neuroscience at the Perelman School of Medicine . Education: A.B. Biology, Princeton University, 1981 Ph.D. Neuroscience, University of Wisconsin-Madison, 1987 Postdoctoral Fellow, California Institute of Technology (Neurogenetics), 1988–1994 Research Focus: The Bonini laboratory exploits the power of Drosophila melanogaster genetics to identify conserved genes and pathways that protect the nervous system from degeneration. By introducing human disease genes into flies, the lab replicates late-onset, progressive neurodegeneration seen in Alzheimer’s, Parkinson’s, Huntington’s, ALS/FTD and age-related cognitive decline. Central themes include: Molecular chaperones and protein-folding pathways that mitigate toxic protein aggregation. microRNA-mediated gene regulation in aging and neurodegeneration. Epigenetic dysregulation in Alzheimer’s disease and its intersection with normal aging. RNA toxicity and repeat-associated non-ATG translation in CAG/polyQ disorders. Metabolic and sleep disturbances linked to TDP-43 and Ataxin-2 dysfunction. Axonal injury responses and the role of Nmnat in maintaining neuronal integrity. Publication Landscape: Across 139 peer-reviewed publications (1986–2024), Bonini’s work spans high-impact journals such as Nature , Science , Cell , Nature Genetics , PNAS and Nature Neuroscience . Early papers established Drosophila polyQ models and identified Hsp70 as a potent suppressor of neural degeneration. Mid-career studies broadened to Parkinson’s α-synuclein toxicity, RNA toxicity in spinocerebellar ataxia, and CREB-binding protein effects on repeat instability. Recent output integrates multi-omics, single-cell and epigenomic approaches to dissect Alzheimer’s disease, glial senescence, m6A/m1A RNA modifications and metabolic dysfunction in sleep. Scientific Honors & Awards: NIH R35 Outstanding Investigator Award (2016) Glenn Award for Research in the Biological Mechanisms of Aging (2015) Member, American Academy of Arts and Sciences (2014) Member, National Academy of Medicine (2012) Member, National Academy of Sciences (2012) Member, American Association for the Advancement of Science (2012) Ellison Medical Foundation Senior Scholar Award in Aging Research (2009) NIH EUREKA Award (2009) David & Lucile Packard Fellowship for Science & Engineering (1997) Basil O’Connor Starter Scholar Award, March of Dimes (1996) John Merck Scholars Award in the Biology of Developmental Disabilities in Children (1995) Funding & Mentorship: Bonini has sustained continuous NIH and private foundation support for over three decades. Her lab has trained a large cohort of graduate students and postdocs who have gone on to independent positions in academia and industry. She teaches advanced courses in Molecular Biology & Genetics (BIOL 221) and Molecular Genetics of Neurological Diseases (BIOL 466), integrating cutting-edge research into graduate and undergraduate curricula. Laboratory & Resources: The Bonini Lab is housed in the Carolyn Lynch and Leidy Laboratories at the University of Pennsylvania, equipped with state-of-the-art Drosophila genetics, molecular biology, imaging and multi-omics platforms. The group maintains extensive fly stocks, transgenic lines and genomic datasets that are shared with the broader scientific community. Collaborative networks span Penn’s Perelman School of Medicine, the Mahoney Institute of Neurological Sciences, and numerous national and international consortia focused on neurodegeneration.

Alexey Petrovمشاهده پروفایل

دانشیار

• Translational Biology
• Ribosome Function
• Protein Synthesis
• +۷ مورد دیگر

Alexey Petrov is an Associate Professor in the Department of Biological Sciences at Auburn University, affiliated with the College of Sciences and Mathematics. His research focuses on the molecular mechanisms of protein synthesis, particularly ribosome dynamics and translational regulation. His research interests lie at the intersection of biochemistry, biophysics, and molecular biology. He investigates how ribosomes achieve high-speed and high-fidelity protein synthesis, how mRNA structure and modifications regulate translation, and how viral elements hijack the translational machinery. His lab employs cutting-edge single-molecule fluorescence techniques and biochemical assays to dissect these processes in real time. The recent publications highlight a strong focus on ribosome translocation, initiation, elongation fidelity, and the impact of mRNA modifications such as 2′-O-methylation and m6A on translation dynamics. His work frequently involves the study of viral internal ribosome entry sites (IRES), providing insights into alternative translation mechanisms. The research is characterized by a deep mechanistic and kinetic understanding of translation, often revealing multiple parallel pathways and dynamic conformational changes. Alexey Petrov received his B.S. from Moscow State University, Russia, followed by a Ph.D. from the University of Maryland, College Park, under Dr. Jonathan Dinman. He completed his postdoctoral training with Dr. Joseph D. Puglisi at Stanford University, where he pioneered single-molecule studies of translation. Postdoctoral fellow with Dr. Joseph D. Puglisi, Stanford University Ph.D. with Dr. Jonathan Dinman, University of Maryland, College Park B.S., Moscow State University, Russia He leads an active research group within Auburn University's Biophysics Cluster, established in 2017. His lab is dedicated to advancing the single-molecule toolbox by developing new instrumentation and data analysis pipelines to make these powerful techniques more accessible. While specific grants are not listed, his publication record in top journals suggests a well-funded and productive research program. He mentors students and postdoctoral researchers in biochemical and biophysical methods, contributing to the training of the next generation of scientists.

Benjamin Wolozinمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Alzheimer's Disease
• Parkinson's Disease
• +۷ مورد دیگر

Benjamin Wolozin is a Professor at the Boston University Chobanian & Avedisian School of Medicine in the Department of Pharmacology , with an adjunct position in Neurology. He specializes in neurodegenerative diseases, particularly Alzheimer's , Parkinson's , and ALS . MD/PhD, Albert Einstein College of Medicine Past Associate Professor at Loyola University Medical Center (1996-2004) Current affiliations: Alzheimer's Disease Center, Boston University Graduate Program for Neuroscience His research investigates RNA binding proteins (RBPs) , stress granules , and liquid-liquid phase separation in neurodegenerative disease. Key projects include the role of TIA1 and HNRNPA2B1 in tauopathy, m6A RNA methylation in Alzheimer's pathology, and development of 3D iPS-neuron/astrocyte assembloids to model dementia. His lab has identified disease-linked circRNA changes and explores nanobodies targeting stress granule components. Recent awards include the Donald B. Lindsley Prize (Society for Neuroscience) and A. E. Bennett Award . He serves on NIH CDIN study sections and editorial boards for Journal of Biological Chemistry and Neurodegenerative Diseases . Grants include multiple NIH R01 and U01 awards for AD/tauopathy research.

Susanne Gerberمشاهده پروفایل

استاد

• Bioinformatics
• Computational Genomics
• Systems Biology
• +۲ مورد دیگر

Susanne Gerber is a Professor at iDNA and Adjunct Director at the Institute of Molecular Biology (IMB), Johannes Gutenberg University Mainz (JGU), affiliated with the Faculty of Biology's Bioinformatics department. Her academic journey includes an Assistant Professorship in Bioinformatics at JGU (2015-2020) and postdoctoral research at Università della Svizzera italiana. Her educational background comprises a PhD in Biophysics from Humboldt University of Berlin (2011), an M.Sc. in Bioinformatics from Free University of Berlin and Konrad Zuse Institute (2007), and a B.Sc. in Bioinformatics from Free University of Berlin and Max Planck Institute (2004). Dr. Gerber's research spans Bioinformatics, Computational Genomics, Systems Biology, Molecular Evolution, and Neuroinformatics , focusing on developing computational frameworks for genomic analysis, neurodegenerative disease modeling, and microbiome interactions. Her work integrates machine learning with multi-omics data to address complex biological questions in molecular evolution and neural systems. Analysis of her 15 most recent publications (2024-2025) reveals a strong emphasis on nanopore sequencing applications for RNA modification detection, deep learning frameworks for genomic data enhancement, and neurobehavioral modeling using AI-driven approaches. Key thematic clusters include epitranscriptomics, chromatin dynamics, and computational psychiatry with ethical AI considerations. Her methodological innovations include tools like COMET for network analysis, CCUT for chromatin data enhancement, and ModiDeC for RNA modification classification, demonstrating translational impact across genomics and neuroscience. Dr. Gerber leads research groups at IMB and iDNA focusing on computational genomics, advising students in bioinformatics and securing grants for AI-driven genomic analysis. Her labs develop open-source tools for nanopore data processing and neuroimaging analysis, fostering collaboration between computational and experimental biologists.

• Structural Biology
• Computational Biology
• Molecular Biophysics
• +۴ مورد دیگر

Bojan Zagrovic is a Professor at the Department of Structural and Computational Biology , University of Vienna. His research focuses on the interplay between protein structure, RNA interactions, and molecular dynamics, particularly in phase separation, enzyme mechanisms, and disease-related mutations. Key research areas: Structural Biology, Computational Biophysics, RNA-Protein Interactions, Phase Separation, and Protein Aggregation. Recent work includes studying FUS RGG3 phase separation, α-mannosidase pathophysiology, and SPOC domain interactions. His publications span molecular dynamics simulations, RNA modifications (e.g., N6-methyladenosine), and structural insights into ciliary proteins like CFAP410. He teaches courses in computational structural biology, molecular biophysics, and quantitative biology.

Michiel Vermeulenمشاهده پروفایل

استاد

• Systems Biology
• Proteomics
• Cellular Differentiation
• +۸ مورد دیگر

Michiel Vermeulen is a Full Professor in Proteomics and Chromatin Biology at the Department of Molecular Biology, Radboud University Nijmegen, Netherlands. He previously held positions as Associate and Assistant Professor at University Medical Center Utrecht (2009-2014) and completed postdoctoral work at Max Planck Institute for Biochemistry (2005-2009) and a PhD at Radboud University (2000-2005). His research focuses on integrative omics approaches to study gene expression regulation in development and disease, particularly through chromatin interactions and post-translational modifications. Education: PhD in Molecular Biology, Radboud University Nijmegen (2000-2005) Postdoc in Proteomics & Signal Transduction, Max Planck Institute Munich (2005-2009) His work pioneers quantitative mass spectrometry technologies to analyze chromatin-associated proteins, including m6A RNA modifications and ubiquitin signaling. He has published 97 papers and received multiple accolades, including ERC Starting and Consolidator Grants, a VIDI award, and membership in the Oncode Institute. His lab leads collaborative studies on chromatin readers, DNA damage response, and transcriptional regulation. Scientific Awards: ERC Consolidator Grant (2017) ERC Starting Grant (2012) Vernieuwingsimpuls VIDI award (2009) Max Planck Institute Junior Research Award (2008) Van Nieuwenhoven Award for Best Master Student (2000) Oncode Institute Founding Member (2017) Vermeulen's lab collaborates internationally and mentors 6 PhD students, 6 postdocs, and technicians, emphasizing high-impact interdisciplinary research in chromatin biology and systems-level gene regulation.